142 related articles for article (PubMed ID: 23091309)
21. Management of drug resistantTB in patients with HIV co-infection.
Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
[TBL] [Abstract][Full Text] [Related]
22. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
[TBL] [Abstract][Full Text] [Related]
23. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
24. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS
PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411
[TBL] [Abstract][Full Text] [Related]
26. Distinct epigenetic regulation in patients with multidrug-resistant TB-HIV co-infection and uninfected individuals.
Marimani M; AlOmar SY; Aldahmash B; Ahmad A; Stacey S; Duse A
Mutat Res; 2020; 821():111724. PubMed ID: 33070028
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial.
Hesseling AC; Kim S; Madhi S; Nachman S; Schaaf HS; Violari A; Victor TC; McSherry G; Mitchell C; Cotton MF;
Int J Tuberc Lung Dis; 2012 Feb; 16(2):192-5. PubMed ID: 22236919
[TBL] [Abstract][Full Text] [Related]
28. Drug-resistant TB prevalence study in 5 health institutions in Haiti.
Hoffmann J; Chedid C; Ocheretina O; Masetti C; Joseph P; Mabou MM; Mathon JE; Francois EM; Gebelin J; Babin FX; Raskine L; Pape JW
PLoS One; 2021; 16(3):e0248707. PubMed ID: 33735224
[TBL] [Abstract][Full Text] [Related]
29. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples.
Hassim S; Shaw PA; Sangweni P; Malan L; Ntshani E; Mathibedi MJ; Stubbs N; Metcalf JA; Eckes R; Masur H; Komati S
Clin Infect Dis; 2010 Apr; 50(7):1053-9. PubMed ID: 20196651
[TBL] [Abstract][Full Text] [Related]
30. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes.
Vidyaraj CK; Chitra A; Smita S; Muthuraj M; Govindarajan S; Usharani B; Anbazhagi S
J Epidemiol Glob Health; 2017 Dec; 7(4):289-294. PubMed ID: 29110871
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.
Zhang L; Xing W; Zhou J; Zhang R; Cheng Y; Li J; Wang G; Liu S; Li Y
BMC Infect Dis; 2020 Aug; 20(1):576. PubMed ID: 32758169
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
[TBL] [Abstract][Full Text] [Related]
34. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
35. Neurocognitive Impairment Risk Among Individuals With Multiple Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection: Implications for Systematic Linkage to and Retention of Care in Tuberculosis/Human Immunodeficiency Virus Treatment.
Tomita A; Ramlall S; Naidu T; Mthembu SS; Padayatchi N; Burns JK
J Nerv Ment Dis; 2019 Apr; 207(4):307-310. PubMed ID: 30920478
[TBL] [Abstract][Full Text] [Related]
36. Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe.
Post FA; Grint D; Werlinrud AM; Panteleev A; Riekstina V; Malashenkov EA; Skrahina A; Duiculescu D; Podlekareva D; Karpov I; Bondarenko V; Chentsova N; Lundgren J; Mocroft A; Kirk O; Miro JM;
J Infect; 2014 Mar; 68(3):259-63. PubMed ID: 24247067
[TBL] [Abstract][Full Text] [Related]
37. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
[TBL] [Abstract][Full Text] [Related]
38. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.
Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG
Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977
[TBL] [Abstract][Full Text] [Related]
39. Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis.
Eldholm V; Rieux A; Monteserin J; Lopez JM; Palmero D; Lopez B; Ritacco V; Didelot X; Balloux F
Elife; 2016 Aug; 5():. PubMed ID: 27502557
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for nosocomial transmission of multidrug-resistant tuberculosis due to Mycobacterium bovis among HIV-infected patients.
Cobo J; Asensio A; Moreno S; Navas E; Pintado V; Oliva J; Gómez-Mampaso E; Guerrero A
Int J Tuberc Lung Dis; 2001 May; 5(5):413-8. PubMed ID: 11336271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
